source
- Bayer's Sunharbo receives FDA approval as first Factor XIa blood thinnerFDA approved Bayer's new oral anticoagulant Sunharbo, marking the first U.S. approval of a Factor XIa inhibitor. The drug blocks Factor XIa, a protein that helps clots grow while playing a minor r…
- FDA warns GLP-1 weight-loss drugs may cause rare eye stroke conditionThe Food and Drug Administration issued a warning that GLP-1 drugs used for weight loss may be linked to a rare eye condition called non-arteritic anterior ischemic optic neuropathy, sometimes desc…